Financial anchor year: FY24. Margin and revenue are as filed for FY24. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY21, the latest filing whose balance sheet reconciled as filed. Days cash on hand is FY22, the most recent year that passed the display gate. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in Brenham, TX. It ran an operating surplus of 18.7% in FY24 on $3.0M of operating revenue. It held 56 days of cash on hand in FY22, its most recent reported liquidity (58th percentile among dialysis facilities on liquidity). Operating margin declined from 22.4% in FY20 to 18.7% in FY24, though it rose 4.6 points in the most recent year. These figures come from filings spanning FY21–FY24: read each by its own year rather than as one current picture.
Operating margin · FY24
+18.7%
▲ 4.6 pts vs FY23
vs dialysis facilities66th pctl of 7,741
Days cash on hand · FY22
56d
all sources
▼ 13.6 days vs FY21
vs dialysis facilities58th pctl
Total operating revenue · FY24
$3.0M
▲ 0.2 $M vs FY23
vs dialysis facilities49th pctl
Total margin · incl. nonoperating · FY24
+18.7%
▲ 4.6 pts vs FY23
vs dialysis facilities69th pctl
Where LIBERTY DIALYSIS BRENHAM sits among dialysis facilities
Operating margin · FY24 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityLIBERTY DIALYSISdialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+18.7% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+18.7% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
56d (FY22)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
0.82× (FY21)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
Not reported in this filing
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
FY23
FY24
Patient revenue
2,696
2,828
3,049
Total operating revenue
2,696
2,828
3,049
Total operating expenses
2,203
2,428
2,479
Operating income
493
400
570
Operating margin %
+18.3%
+14.1%
+18.7%
Other non-operating, net
0
0
0
Net income
493
400
570
Net income %
+18.3%
+14.1%
+18.7%
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Economic context: 11.4% of county personal income is Medicare/Medicaid medical benefits; 23.0% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
